Search results

Registration for this event has now closed due to a large number of expressions of interest. Those who obtained a place will be contacted on Monday 13th February 2017.

It is with great sadness that we hear of the news of the death of a close friend of the Health Research Authority, Dr Richard Tiner. A former general practitioner in the South West of England for many years, Richard was medical director of the Association of British Pharmaceutical Industry from 1996 – 2009.

What are the circumstances under which it is acceptable to use confidential patient and service user information without consent for purposes beyond direct patient care?

The range of independent advice and expertise available to the Health Research Authority has been broadened with the expansion in March of the HRA’s national panel of experts.

If you are a researcher who needs to explain the risks of ionising radiation to your study participants, then we have produced some generic statements to help you.

The Annual NHS R&D Forum is taking place in Manchester on 15 - 16 May 2017 – the must-attend meeting of the year for those working in health and care research management, support and leadership.

Biotechnology company Amgen was keen to get HRA Approval for an international research study into the effectiveness of a new treatment for patients with aggressive B-cell Non-Hodgkin’s lymphoma.

The first study to ever go through HRA Approval has now been completed. The study, led by NHS South Norfolk Clinical Commissioning Group (CCG), looked into interagency working across local health agencies, local authorities and the police in safeguarding adults, and involved interviews with members of the local safeguarding adults board. The application was made in May 2015, during HRA Approval’s phased roll-out.

Health and social care researchers used to be faced with a very complex regulatory system – everyone agreed we needed a new approach. So we consulted with a wide range of stakeholders to develop HRA Approval, which brings together the assessment of legal compliance and the ethics review into one streamlined system.

Researchers working across the four United Kingdom countries should find it easier to set up and carry out health research across the NHS and Health and Social Care in Northern Ireland (HSC). This is thanks to the UK research approval bodies carrying out a new programme of work to implement.

We’ve worked with the NHS R&D Forum to create a short animation to explain HRA Approval and to illustrate the experience of researchers applying for approvals before and after its development.

Twitter users searching for #HRAtips can get advice on submitting studies for HRA Approval as part of a new campaign to help applicants avoid common mistakes in their research proposals.

‘Significant progress’ has been made in medical research regulation and governance over the past 5 years, according to a report of an Academy of Medical Sciences workshop published this week.

A combined IRAS form that merges the Research Ethics Committee (REC) and R&D forms is now being used across the UK.

We have developed six new eLearning modules as an aid for researchers, R&D staff, study sponsors, research ethics committee members and the wider research community.

The use of electronic signatures and authorisations is becoming increasingly common. We’ve had queries about their validity in protocols and other documents and we’d like to clarify that we accept them as an alternative to ink signatures.

Janet Wisely is to step down as Chief Executive of the Health Research Authority. Janet has experienced an unexpected and life changing health situation, which has meant significant adjustments. After careful reflection and discussion with her family and colleagues, she is now stepping down after concluding that she is unlikely to recover the mental or physical stamina that is required for that very demanding role.

It is a source of real pride across the HRA to see how many health research studies the HRA has reviewed. Since we fully implemented HRA Approval last March, more than 5,000 applications have been approved by our expert teams.

If you are a regular visitor to the HRA’s current website, you may share the view of many of our users that the site is increasingly difficult to navigate and it can be hard to find the information you need.

The HRA is working with the devolved nations to develop an integrated, UK-wide approach for undertaking technical reviews on research involving pharmacy and/or ionising radiation.